Concepedia

Brittany Anderton

BA

10

Publications

1.3K

Citations

10

H-Index

2009

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, Davis

Medizinische Hochschule Hannover

Broad Center

Brittany Anderton is an author at University of California, San Francisco specializing in medicine, tumor microenvironment, and tumor biology.

ORCID

Top concepts

Publications per year

2009–2021

10

Publications

10

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

Roman Camarda, Alicia Y. Zhou, Rebecca A. Kohnz et al. · Nature Medicine · 2016 · 523 citations · Full text

, , +7

13C-Pyruvate Imaging Reveals Alterations in Glycolysis that Precede c-Myc-Induced Tumor Formation and Regression

Simon Hu, Asha Balakrishnan, Robert Bok et al. · Cell Metabolism · 2011 · 237 citations · Full text

, , +7

PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

Dai Horiuchi, Roman Camarda, Alicia Y. Zhou et al. · Nature Medicine · 2016 · 164 citations

, , +11

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer

Lionel Lim, Asha Balakrishnan, Noelle E. Huskey et al. · Hepatology · 2013 · 115 citations · Full text

<scp>MYC</scp> ‐driven inhibition of the glutamate‐cysteine ligase promotes glutathione depletion in liver cancer

Brittany Anderton, Roman Camarda, Sanjeev Balakrishnan et al. · EMBO Reports · 2017 · 76 citations · Full text

Rows per page

1–5 of 10